» Articles » PMID: 30826287

Magnesium Supplementation in the Treatment of Pseudoxanthoma Elasticum: A Randomized Trial

Citing Articles

The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate.

Clotaire L, Rubera I, Duranton C, Gal J, Chamorey E, Humeau H Trials. 2025; 26(1):30.

PMID: 39881395 PMC: 11776210. DOI: 10.1186/s13063-024-08666-w.


Cutaneous signs of selected cardiovascular disorders: A narrative review.

Asif M, Yousuf M, Farooqui U, Nashwan A, Ullah I Open Med (Wars). 2024; 19(1):20240897.

PMID: 38463529 PMC: 10921438. DOI: 10.1515/med-2024-0897.


Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial.

Murcia Casas B, Carrillo Linares J, Baquero Aranda I, Rioja Villodres J, Merino Bohorquez V, Gonzalez Jimenez A Int J Mol Sci. 2023; 24(5).

PMID: 36902331 PMC: 10003519. DOI: 10.3390/ijms24054899.


Serum Calcification Propensity T50 Associates with Disease Severity in Patients with Pseudoxanthoma Elasticum.

Nollet L, Van Gils M, Fischer S, Campens L, Karthik S, Pasch A J Clin Med. 2022; 11(13).

PMID: 35807012 PMC: 9267205. DOI: 10.3390/jcm11133727.


[Pseudoxanthoma elasticum: the dermatologist as a guide].

Burghaus J, Schneiderbauer R, Toberer F Dermatologie (Heidelb). 2022; 73(10):804-808.

PMID: 35428953 PMC: 9512710. DOI: 10.1007/s00105-022-04987-6.